Valproic Acid for a Treatment of Retinitis Pigmentosa: Reasons for Optimism and Caution.
作者信息
Todd Levi, Zelinka Christopher
机构信息
Department of Neuroscience, College of Medicine, Ohio State University, Columbus, Ohio 43210, and
Department of Biological Science, Florida State University, Tallahassee, Florida 32306.
出版信息
J Neurosci. 2017 May 24;37(21):5215-5217. doi: 10.1523/JNEUROSCI.0774-17.2017.
Abstract
摘要
相似文献
1
Valproic Acid for a Treatment of Retinitis Pigmentosa: Reasons for Optimism and Caution.丙戊酸用于治疗视网膜色素变性：乐观与谨慎的理由
J Neurosci. 2017 May 24;37(21):5215-5217. doi: 10.1523/JNEUROSCI.0774-17.2017.
2
Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic Models of Retinitis Pigmentosa.丙戊酸治疗在四种视网膜色素变性转基因模型中通过组蛋白去乙酰化酶抑制剂活性介导的相反作用。
J Neurosci. 2017 Jan 25;37(4):1039-1054. doi: 10.1523/JNEUROSCI.1647-16.2016.
3
Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa.丙戊酸治疗可能对非显性形式的视网膜色素变性有害。
Br J Ophthalmol. 2012 Aug;96(8):1154-5. doi: 10.1136/bjophthalmol-2012-301950. Epub 2012 May 12.
4
Histone Deacetylase: Therapeutic Targets in Retinal Degeneration.组蛋白去乙酰化酶：视网膜变性中的治疗靶点
Adv Exp Med Biol. 2016;854:455-61. doi: 10.1007/978-3-319-17121-0_61.
5
Lack of scientific rationale for use of valproic acid for retinitis pigmentosa.
Br J Ophthalmol. 2011 May;95(5):744. doi: 10.1136/bjo.2010.198176. Epub 2010 Dec 3.
6
Methodological Insights for Randomized Clinical Trials of Retinitis Pigmentosa: Lessons Learned From a Trial of Valproic Acid.视网膜色素变性随机临床试验的方法学见解：从丙戊酸试验中汲取的经验教训
JAMA Ophthalmol. 2018 Aug 1;136(8):857-858. doi: 10.1001/jamaophthalmol.2018.1167.
7
Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease.丙戊酸对变应性气道疾病小鼠模型气道高反应性和气道重塑的保护作用。
Epigenetics. 2011 Dec;6(12):1463-70. doi: 10.4161/epi.6.12.18396.
8
The conclusions of Clemson et al concerning valproic acid are premature.
Br J Ophthalmol. 2011 Jan;95(1):153; author reply 153-4. doi: 10.1136/bjo.2010.194373. Epub 2010 Oct 22.
9
Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition.
Bioorg Med Chem Lett. 2007 Aug 15;17(16):4491-4. doi: 10.1016/j.bmcl.2007.06.006. Epub 2007 Jun 6.
10
Current Pharmacological Concepts in the Treatment of the Retinitis Pigmentosa.当前治疗色素性视网膜炎的药理学概念。
Adv Exp Med Biol. 2018;1074:439-445. doi: 10.1007/978-3-319-75402-4_54.
引用本文的文献
1
Inhibition of Epigenetic Modifiers LSD1 and HDAC1 Blocks Rod Photoreceptor Death in Mouse Models of Retinitis Pigmentosa.抑制表观遗传修饰剂 LSD1 和 HDAC1 可阻止视网膜色素变性的小鼠模型中的 Rod 光感受器死亡。
J Neurosci. 2021 Aug 4;41(31):6775-6792. doi: 10.1523/JNEUROSCI.3102-20.2021. Epub 2021 Jun 30.
2
Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.大规模表型药物筛选鉴定出斑马鱼和视网膜色素变性小鼠模型中的神经保护剂。
Elife. 2021 Jun 29;10:e57245. doi: 10.7554/eLife.57245.
3
SAHA is neuroprotective in in vitro and in situ models of retinitis pigmentosa.SAHA 在视网膜色素变性的体外和原位模型中具有神经保护作用。
Mol Vis. 2021 Apr 2;27:151-160. eCollection 2021.
4
Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning.青光眼基因修饰动物模型的最新进展及其在药物重定位中的作用。
Br J Ophthalmol. 2019 Feb;103(2):161-166. doi: 10.1136/bjophthalmol-2018-312724. Epub 2018 Oct 26.
本文引用的文献
1
Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic Models of Retinitis Pigmentosa.丙戊酸治疗在四种视网膜色素变性转基因模型中通过组蛋白去乙酰化酶抑制剂活性介导的相反作用。
J Neurosci. 2017 Jan 25;37(4):1039-1054. doi: 10.1523/JNEUROSCI.1647-16.2016.
2
Autophagy supports survival and phototransduction protein levels in rod photoreceptors.自噬维持视杆光感受器的存活及光转导蛋白水平。
Cell Death Differ. 2015 Mar;22(3):488-98. doi: 10.1038/cdd.2014.229. Epub 2015 Jan 9.
3
Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.丙戊酸对Rd1和Rd10视网膜变性小鼠光感受器丧失的不同影响。
Mol Vis. 2014 Nov 4;20:1527-44. eCollection 2014.
4
High prevalence of PRPH2 in autosomal dominant retinitis pigmentosa in france and characterization of biochemical and clinical features.法国常染色体显性遗传视网膜色素变性中 PRPH2 的高患病率及生化和临床特征的描述。
Am J Ophthalmol. 2015 Feb;159(2):302-14. doi: 10.1016/j.ajo.2014.10.033. Epub 2014 Nov 5.
5
Photoactivation-induced instability of rhodopsin mutants T4K and T17M in rod outer segments underlies retinal degeneration in X. laevis transgenic models of retinitis pigmentosa.在非洲爪蟾视网膜色素变性转基因模型中，光激活诱导视杆外段视紫红质突变体T4K和T17M的不稳定性是视网膜变性的基础。
J Neurosci. 2014 Oct 1;34(40):13336-48. doi: 10.1523/JNEUROSCI.1655-14.2014.
6
Retinal implants: a systematic review.视网膜植入物：系统评价。
Br J Ophthalmol. 2014 Jul;98(7):852-6. doi: 10.1136/bjophthalmol-2013-303708.
7
Vitamin A and fish oils for retinitis pigmentosa.维生素A和鱼油用于治疗视网膜色素变性。
Cochrane Database Syst Rev. 2013 Dec 19;2013(12):CD008428. doi: 10.1002/14651858.CD008428.pub2.
8
Genes and mutations causing retinitis pigmentosa.导致视网膜色素变性的基因和突变。
Clin Genet. 2013 Aug;84(2):132-41. doi: 10.1111/cge.12203. Epub 2013 Jun 19.
9
Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush.丙戊酸盐促进视神经钳夹大鼠模型中视网膜神经节细胞的存活。
Neuroscience. 2012 Nov 8;224:282-93. doi: 10.1016/j.neuroscience.2012.07.056. Epub 2012 Aug 4.
10
Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa.丙戊酸治疗可能对非显性形式的视网膜色素变性有害。
Br J Ophthalmol. 2012 Aug;96(8):1154-5. doi: 10.1136/bjophthalmol-2012-301950. Epub 2012 May 12.
Zotero 插件